-
How Rebates Drive Up Prescription Drug Costs for Consumers
Auditor General Eugene DePasquale releases a new special report on how manufacturers' rebates artificially inflate the prices people pay for prescription drugs. -
Secretary Alex M. Azar on Drug Rebates
Secretary Alex Azar is putting American Patients First by fighting for lower drug pricing.Comments
-
Drug Kickbacks: Caught on Camera
It’s illegal in Ontario and drives up the price of generic drugs across Canada. So why are pharmacists taking what are called rebates, which are like kickbacks, from some of the the largest drug suppliers in the world?Comments
-
Cigna CEO Says Drug-Rebate Overhaul Won't Impact Company
Cigna CEO David Cordani talks about the impact of President Donald Trump's plan to lower drugs costs on his company.Comments
-
Azar on the Trump Administration Drug Rebate Proposal
Health & Human Services Secretary Alex Azar on efforts to rein in drug prices, mounting concerns over teen use of ecigarettes and Sen. Kamala Harris proposing Medicare-for-all.Comments
-
Sec. Azar on How New Proposal "Brings Transparency" to Drug Pricing
A new rule bans pharmaceutical companies from providing rebates to middlemen and insurers in exchange for choosing their drugs.Comments
-
Trump's Drug Pricing Plan Explained By HHS Secretary Azar
U.S. Health & Human Services Secretary Alex Azar discusses President Donald Trump's proposal targeting rebates to pharmacy benefit managers in an effort to lower prescription drug prices.Comments
-
Drug Kickbacks: Caught on Camera
It’s illegal in Ontario and drives up the price of generic drugs across Canada. So why are pharmacists taking what are called rebates, which are like kickbacks, from some of the the largest drug suppliers in the world?Comments
-
Prescription Drugs : The Costco Kickbacks
Secret audio tapes and an exclusive television interview with an industry whistleblower reveal a shady practice that is industry-wide.Comments
-
Drug Money
People & Power investigates fraud and corruption running through the veins of the US pharmaceutical industry.Comments
Comments